These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 10432945)

  • 1. [New developments in therapy of non-Hodgkin lymphomas with monoclonal antibodies].
    Buske C; Feuring-Buske M; Unterhalt M; Hiddemann W
    Dtsch Med Wochenschr; 1999 Jul; 124(27):842-7. PubMed ID: 10432945
    [No Abstract]   [Full Text] [Related]  

  • 2. Monoclonal antibody therapy for indolent lymphomas.
    Grossbard ML; Nadler LM
    Semin Oncol; 1993 Oct; 20(5 Suppl 5):118-35. PubMed ID: 8211202
    [No Abstract]   [Full Text] [Related]  

  • 3. [Radioimmunoconjugates: therapy of non-Hodgkin lymphomas and colorectal carcinomas].
    Griesinger F; Trümper L; Becker W
    Internist (Berl); 2001 Jun; 42(6):860-4, 866-73. PubMed ID: 11449633
    [No Abstract]   [Full Text] [Related]  

  • 4. Development of targeted therapies for B-cell non-Hodgkin lymphoma and multiple myeloma.
    Hernandez-Ilizaliturri FJ; Gowda A; Czuczman MS
    Clin Adv Hematol Oncol; 2004 Sep; 2(9):606-18. PubMed ID: 16163245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Monoclonal antibody therapy for malignant lymphoma].
    Buske C; Dreyling M; Unterhalt M; Hiddemann W
    Med Klin (Munich); 2005 Jan; 100(1):14-24. PubMed ID: 15654538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical trials referral resource. Current clinical trials of the anti-CD20 monoclonal antibody rituximab.
    Davis T; Gore-Langton RE; Cheson BD
    Oncology (Williston Park); 2000 Oct; 14(10):1437, 1440-3. PubMed ID: 11098509
    [No Abstract]   [Full Text] [Related]  

  • 7. Prospects for the management of non-Hodgkin's lymphomas with monoclonal antibodies and immunoconjugates.
    Press OW
    Cancer J Sci Am; 1998 Jul; 4 Suppl 2():S19-26. PubMed ID: 9672771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibodies in the treatment of non-Hodgkin's lymphoma patients.
    Coiffier B
    Haematologica; 1999 Jun; 84 Suppl EHA-4():14-8. PubMed ID: 10907457
    [No Abstract]   [Full Text] [Related]  

  • 9. [Monoclonal antibodies in therapy of malignant lymphomas].
    Buske C; Engert A; Schnell R; Diehl V; Hiddemann W
    Internist (Berl); 1998 Dec; 39(12):1205-14. PubMed ID: 10198827
    [No Abstract]   [Full Text] [Related]  

  • 10. Rituximab and its role as maintenance therapy in non-Hodgkin lymphoma.
    Collins-Burow B; Santos ES
    Expert Rev Anticancer Ther; 2007 Mar; 7(3):257-73. PubMed ID: 17338647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal antibodies in advanced B-cell lymphomas.
    Ujjani C; Cheson BD
    Oncology (Williston Park); 2010 Feb; 24(2):156-66. PubMed ID: 20361466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapy for non-Hodgkin's lymphoma: monoclonal antibodies and vaccines.
    Maloney DG
    J Clin Oncol; 2005 Sep; 23(26):6421-8. PubMed ID: 16155029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiolabeled antibody therapy of B-cell lymphomas.
    Press OW
    Semin Oncol; 1999 Oct; 26(5 Suppl 14):58-65. PubMed ID: 10561019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment with Rituximab for relapsing immune thrombocytopenic purpura (ITP) associated with low-grade non-Hodgkin's lymphoma.
    Shvidel L; Klepfish A; Berrebi A
    Am J Hematol; 2001 Jul; 67(3):213-4. PubMed ID: 11391724
    [No Abstract]   [Full Text] [Related]  

  • 15. Newer monoclonal antibodies for hematological malignancies.
    Castillo J; Winer E; Quesenberry P
    Exp Hematol; 2008 Jul; 36(7):755-68. PubMed ID: 18565392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New therapeutic approaches to non-Hodgkin's lymphomas.
    Lambert JF; Elfenbein GJ
    Med Health R I; 2003 Aug; 86(8):236-9. PubMed ID: 14582217
    [No Abstract]   [Full Text] [Related]  

  • 17. Harnessing the energy: development of radioimmunotherapy for patients with non-Hodgkin's lymphoma.
    Gregory SA; Hohloch K; Gisselbrecht C; Tobinai K; Dreyling M
    Oncologist; 2009; 14 Suppl 2():4-16. PubMed ID: 19819920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody-targeted therapy for low-grade lymphoma.
    Vose JM
    Semin Hematol; 1999 Oct; 36(4 Suppl 6):15-20. PubMed ID: 10530712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II clinical trial of bolus infusion anti-B4 blocked ricin immunoconjugate in patients with relapsed B-cell non-Hodgkin's lymphoma.
    Multani PS; O'Day S; Nadler LM; Grossbard ML
    Clin Cancer Res; 1998 Nov; 4(11):2599-604. PubMed ID: 9829722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimizing the treatment of patients with rituximab-pretreated recurrent indolent non-Hodgkin lymphoma.
    Leonard JP; Gregory SA; Maloney DG; Vose JM; Younes A; Zelenetz AD
    Clin Adv Hematol Oncol; 2008 Jun; 6(6):437-45. PubMed ID: 18567989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.